70 related articles for article (PubMed ID: 27958261)
1. Serum uromodulin concentrations correlate with glomerular filtration rate in patients with chronic kidney disease.
Fedak D; Kuźniewski M; Fugiel A; Wieczorek-Surdacka E; Przepiórkowska-Hoyer B; Jasik P; Miarka P; Dumnicka P; Kapusta M; Solnica B; Sułowicz W
Pol Arch Med Wewn; 2016 Dec; 126(12):995-1004. PubMed ID: 27958261
[TBL] [Abstract][Full Text] [Related]
2. Plasma Uromodulin Correlates With Kidney Function and Identifies Early Stages in Chronic Kidney Disease Patients.
Steubl D; Block M; Herbst V; Nockher WA; Schlumberger W; Satanovskij R; Angermann S; Hasenau AL; Stecher L; Heemann U; Renders L; Scherberich J
Medicine (Baltimore); 2016 Mar; 95(10):e3011. PubMed ID: 26962815
[TBL] [Abstract][Full Text] [Related]
3. Association of clinical characteristics with urine uromodulin in children with chronic kidney disease.
Faulkner SC; Matheson MB; Greenberg JH; Garimella PS; Furth SL; Ix JH; Bakhoum CY
Pediatr Nephrol; 2023 Nov; 38(11):3859-3862. PubMed ID: 36988691
[TBL] [Abstract][Full Text] [Related]
4. Association of Apical Periodontitis with Different Stages of Chronic Kidney Disease Measured by Glomerular Filtration Rate and Systemic Markers: An Observational Study.
Lamba J; Mittal S; Tewari S; Jain D; Tewari S; Duhan J; Sangwan P; Kumar V
J Endod; 2023 Nov; 49(11):1472-1479. PubMed ID: 37640201
[TBL] [Abstract][Full Text] [Related]
5. Salivary creatinine as a diagnostic tool for evaluating patients with chronic kidney disease.
Temilola DO; Bezuidenhout K; Erasmus RT; Stephen L; Davids MR; Holmes H
BMC Nephrol; 2019 Oct; 20(1):387. PubMed ID: 31660882
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of presepsin considering renal function.
Miyoshi M; Inoue Y; Nishioka M; Ikegame A; Nakao T; Kishi S; Doi T; Nagai K
PLoS One; 2019; 14(9):e0215791. PubMed ID: 31490935
[TBL] [Abstract][Full Text] [Related]
7. Clinical value of serum MMP-3 in chronic kidney disease.
Fu Y; Song C; Qin Y; Zheng T; Zhou X; Zhao X; Zou J; Huang B
Clin Chim Acta; 2024 Jan; 553():117725. PubMed ID: 38128817
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of amphiregulin in patients with chronic kidney disease.
Osakabe Y; Taniguchi Y; Hamada Ode K; Shimamura Y; Inotani S; Nishikawa H; Matsumoto T; Horino T; Fujimoto S; Terada Y
Clin Exp Nephrol; 2024 May; 28(5):421-430. PubMed ID: 38402497
[TBL] [Abstract][Full Text] [Related]
9. Ghrelin Levels and Decreased Kidney Function in Patients with Early Stages of Chronic Kidney Disease Against the Background of Obesity.
Gubina NV; Kupnovytska IH; Mishchuk VH; Markiv HD
J Med Life; 2020; 13(4):530-535. PubMed ID: 33456602
[TBL] [Abstract][Full Text] [Related]
10. Uromodulin concentrations are not associated with incident CKD among persons with coronary artery disease.
Shlipak MG; Li Y; Fox C; Coresh J; Grunfeld C; Whooley M
BMC Nephrol; 2011 Jan; 12():2. PubMed ID: 21235779
[TBL] [Abstract][Full Text] [Related]
11. Routine serum creatinine measurements: how well do we perform?
Hoste L; Deiteren K; Pottel H; Callewaert N; Martens F
BMC Nephrol; 2015 Feb; 16():21. PubMed ID: 25803560
[TBL] [Abstract][Full Text] [Related]
12. Polymorphism in the
Šalamon Š; Bevc S; Ekart R; Hojs R; Potočnik U
Genes (Basel); 2021 May; 12(6):. PubMed ID: 34071541
[TBL] [Abstract][Full Text] [Related]
13. Cessation of Bezafibrate in patients with chronic kidney disease improves renal function.
Zingerman B; Ziv D; Feder Krengel N; Korzets A; Matok I
Sci Rep; 2020 Nov; 10(1):19768. PubMed ID: 33188240
[TBL] [Abstract][Full Text] [Related]
14. Unveiling the Hidden Power of Uromodulin: A Promising Potential Biomarker for Kidney Diseases.
Thielemans R; Speeckaert R; Delrue C; De Bruyne S; Oyaert M; Speeckaert MM
Diagnostics (Basel); 2023 Sep; 13(19):. PubMed ID: 37835820
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular risk and kidney function profiling using conventional and novel biomarkers in young adults: the African-PREDICT study.
Degenaar A; Jacobs A; Kruger R; Delles C; Mischak H; Mels C
BMC Nephrol; 2023 Apr; 24(1):96. PubMed ID: 37055746
[TBL] [Abstract][Full Text] [Related]
16. Uromodulin and CKD: insight into variant pathogenicity.
Franceschini N; Berg JS
Kidney Int; 2023 Feb; 103(2):248-250. PubMed ID: 36681451
[No Abstract] [Full Text] [Related]
17. Validation of Diagnostic Utility of Salivary Urea in Patients with Chronic Kidney Disease in Chennai: A Cross-Sectional Study.
Nagarathinam AE; Dineshkumar T; Rajkumar K; Rameshkumar A; Shruthi TA; Alzahrani KJ; Alzahrani FM; Halawani IF; Patil S
Niger J Clin Pract; 2023 Dec; 26(12):1868-1875. PubMed ID: 38158355
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of phosphatidylethanolamine binding protein 4 levels in patients receiving nursing interventions for advanced chronic kidney disease.
He P; Zhou C; Shen H
J Int Med Res; 2021 Mar; 49(3):300060521996179. PubMed ID: 33752499
[TBL] [Abstract][Full Text] [Related]
19. Chronic kidney disease in children: Using novel biomarkers as predictors of disease.
Uwaezuoke SN; Ayuk AC; Muoneke VU; Mbanefo NR
Saudi J Kidney Dis Transpl; 2018; 29(4):775-784. PubMed ID: 30152412
[TBL] [Abstract][Full Text] [Related]
20. Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease.
Emrich IE; Zawada AM; Martens-Lobenhoffer J; Fliser D; Wagenpfeil S; Heine GH; Bode-Böger SM
Clin Res Cardiol; 2018 Mar; 107(3):201-213. PubMed ID: 29101459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
